New research published in Rheumatology, the international, peer-reviewed scientific journal, has suggested that systemic lupus erythematosus (SLE) patients of African descent and from lower socioeconomic groups face a higher risk of primary cardiac disease. However, those taking anti-malarial drugs reduce their risk.The research found that 14% of patients experience cardiac problems as a result of the auto-immune disorder within five years of diagnosis.
More...
More...